BiotechTube

Zolpidem MR + Zolpidem IR

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Sleep Initiation and Maintenance Disorders

Conditions

Sleep Initiation and Maintenance Disorders, Primary Insomnia

Trial Timeline

Oct 1, 2009 → Apr 1, 2011

NCT ID
NCT01181232

About Zolpidem MR + Zolpidem IR

Zolpidem MR + Zolpidem IR is a approved stage product being developed by Astellas Pharma for Sleep Initiation and Maintenance Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT01181232. Target conditions include Sleep Initiation and Maintenance Disorders, Primary Insomnia.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01181232ApprovedCompleted

Competing Products

20 competing products in Sleep Initiation and Maintenance Disorders

See all competitors
ProductCompanyStageHype Score
Daridorexant + PlaceboIdorsiaPhase 1
28
LY2422347 + placeboEli LillyPhase 2
52
LY2624803 - Solution + LY2624803 - Capsule + Placebo - Solution + Placebo - CapsuleEli LillyPhase 1
33
Zolpidem MR + EstazolamAstellas PharmaApproved
85
zolpidem MR + nitrazepam + placeboAstellas PharmaPhase 3
77
FK199B + ZolpidemAstellas PharmaPhase 3
77
Zolpidem MR + ZolpidemAstellas PharmaPhase 3
77
Sivopixant + Placebo + Acetazolamide + SASS-001ShionogiPhase 2
52
Placebo + Lemborexant 10 mg + Lemborexant 25 mg + Placebo + Lemborexant 10 mgEisaiPhase 1
33
Lemborexant + PlaceboEisaiApproved
85
Zonisamide + PlaceboEisaiPhase 2
52
Lemborexant 2.5 mg + Lemborexant 5 mg + Lemborexant 10 mg + Lemborexant 15 mg + Lemborexant-matched placeboEisaiPhase 2
52
Placebo + Lemborexant 10 mg + Placebo + Lemborexant 10 mgEisaiPhase 1
33
LemborexantEisaiPhase 2
52
Lemborexant + PlaceboEisaiPhase 3
77
LemborexantEisaiPre-clinical
23
Istradefylline (KW-6002)Kyowa KirinPhase 2
52
Eloralintide + PlaceboEli LillyPhase 3
77
Tirzepatide + PlaceboEli LillyPhase 3
77
Eszopiclone + PlaceboSumitomo PharmaPhase 2
52

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85